Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Status Of AI Regulation On Drug Development
As AI capabilities scale, the FDA expects sponsors and their outsourcing partners to treat AI like any other regulated, computerized system that can influence safety, effectiveness, or quality–define the role, document credibility, control the lifecycle, and monitor performance. read more
Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Ecolab Opens Resin Manufacturing Facility in China
Tuesday, September 15, 2026
Ecolab Life Sciences has opened a resin manufacturing facility in Quzhou, China, expanding the company’s capacity to produce materials used in ... read more
Endpoint Clinical Acquires Bluefin
Tuesday, September 15, 2026
Endpoint Clinical has acquired Bluefin, a provider of clinical supply forecasting and planning technology. read more
FAREVA Acquires Pharmaceutical Manufacturing Site in Türkiye
Tuesday, September 15, 2026
FAREVA has acquired a pharmaceutical production site in Lüleburgaz, Türkiye, expanding its manufacturing network and adding nearly 750 employees. read more
Sygnature Discovery Establishes DEL Screening Collaboration with X-Chem
Monday, September 14, 2026
Sygnature Discovery has established a formal collaboration with X-Chem to support the delivery of DEL screening within its integrated drug discovery ... read more
Transcenta Licenses Continuous Bioprocessing Technology to WuXi Biologics
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB ... read more